Multi-institutional experience with COVID-19 convalescent plasma in children.
Cyril JacquotOren GordonDaniel NolandJeffrey R DonowitzEmily R LevySanjay JainZachary WillisCasey RimlandMichele LoiAntonio ArrietaKyle AnnenNoelle DrapeauStephanie OsborneMonica I ArduraSatyam AroraElise ZivickMeghan DelaneyPublished in: Transfusion (2023)
CCP was found to be safe and well-tolerated in children. CCP was frequently given concurrently with other COVID-19-directed treatments with improvement in clinical severity scores ≥7 days after CCP, but efficacy could not be evaluated in this study.